UNSPSC 51241556: Levobunolol/polyvinyl alcohol

Combination drugs that treat diseases of the eyes Polyvinil alcohol Levobunolol is a beta-adrenergic antagonist used for the reduction of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

UNSPSC 51241556 Levobunolol/polyvinyl alcohol is a Commodity code representing ophthalmic pharmaceutical products—specifically, a combination eye drop medication used for glaucoma treatment. The recent state and local procurement activity under this code shows minimal relevant solicitation activity; no recent opportunities explicitly solicit levobunolol/polyvinyl alcohol or narrow-scope ophthalmic medications matching this specific formulation. The opportunities posted under or near this code span broader pharmaceutical, medical supplies, and health services categories—naloxone procurement, emergency medical services pharmaceuticals, forensic drug standards, generic multi-source pharmaceuticals through cooperative purchasing, and county wellness clinic services—none of which directly align with levobunolol/polyvinyl alcohol use cases or purchasing patterns. The issuing bodies in the recent dataset include county health departments, municipal fire departments, state cooperative purchasing alliances, and county health services divisions, but their solicitations focus on emergency response, forensic analysis, employee wellness, and broad-spectrum pharmaceutical distribution rather than ophthalmic specialty medications. Geographic activity spans Florida, Arizona, Minnesota, Arkansas, and Texas based on recent posts, but none name ophthalmology, glaucoma treatment, or eye care procurement as a stated objective.

The absence of recent levobunolol/polyvinyl alcohol solicitations suggests this Commodity code either sees infrequent state and local procurement activity or is tagged inconsistently in practice. Buyers of ophthalmic medications at the state and local level—primarily health departments, public health clinics, and correctional facilities—may procure such products under broader pharmaceutical family codes, cooperative purchasing vehicles with established vendor networks, or through group purchasing organizations rather than standalone competitive solicitations. Business development professionals should monitor state Medicaid agencies, county health systems with optometry or ophthalmology clinics, and state prison healthcare procurement for relevant opportunities, while noting that recent state and local procurement data under this specific code does not support active pursuit activity at this time.